New anti-mycobacterial peptide antibiotics, Lariatin and Calpinactam
- At: 2010 FIP Congress in Lisbon (Portugal)
- Type: Presentation
- By: TOMODA, Hiroshi (Kitasato University, Tokyo, Japan)
Our research group has focused on drug discovery from microorganisms. Tuberculosis is the greatest single infections cause of mortality in the world. For discovery of new antimycobacterial agents, we have searched for microbial metabolites that selectively inhibit the growth of Mycobacterium smegmatis. Over 30,000 culture broths of actinomycetes,.. The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.